Pericoital Oral LNG

Description: Levonorgestrel (LNG) 0.75 mg tablets

Product Details

User: Female

Hormonal: Yes

Delivery Method: Oral

Duration Type: Pericoital

Dose: 0.75 mg

Active Pharmaceutical Ingredient (API):
  • levonorgestrel

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: HRA Pharma, Gynuity Health Projects, PATH

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Phase III

Active Development: Yes

Additional Information

References:

Vertical Tabs

Print